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Summary: A method comparsion of the 4 h-elastase/ai-protein-
ase-inhibitor test kit with a newly developed 2 h-version was
performed. The within-run and between-days coefficients of
variation as well as the recovery of the assigned values were
satisfactory for both test kits. Good agreement was found
between the 2h- and 4h-test kits using specimens from 160
patients. In conclusion, the 2h-test kit can be used as an
alternative for the determination of elastase/ai-proteinase-in-
hibitor complex.
Introduction
Elastase/arproteinase-inhibitor complex is a marker for inflam-
matory disease activity in patients with rheumatic diseases (1),
active Crohn disease (2), postoperative infections after major
abdominal surgery (3) and multiple trauma (4) as well as for
monitoring therapy (5). The present study was undertaken to
verify the performance criteria of the 2 h-test kit versus the 4 li-
test kit.
Material and Methods
Origin of specimen
K.2-EDTA blood samples (3 ml) were drawn randomly from
160 hospitalized patients (male/female ratio: 78/82, age range:
3—80 years) and immediately centrifuged at 150 g for 10 min
at 20 °C. The plasma supernatants were stored at -30 °C until
use.
2 h- and 4 h-test kits of elastase/oti-proteinase-inhib-
itor
The elastase/arproteinase-inhibitor test kits (2 h-test: lot. No.
FO; 4 h-test: No. 75366927) were kindly supplied by Dr. S.
Neumann, Biochemische Forschung Merck, D-6100 Darmstadt
(6). The 2 h-test kit differed from the 4 h-test kit only in the
shorter incubation times of antibody-alkaline-phospfaatase-con-
jugate (30 min) and substrate (30 min). To assess the linearity
of the 2 h-test kit version, a plasma sample from one patient
(elastase/ctj-proteinase-inhibitor concentration: 1746 μg/l) was
Tab. 1. Imprecision within-run, between-days and accuracy for the 21l·· and 4 h-test kits of elastase/ai-proteinase-inhibitor-
enzyme-Hnked-immunosorbent assay (CV = coefficient of variation)
Imprecision within run
2 fa-
version
4 fa-
version
Concen-
tration
χ fog/i)
178.7
353.6
176.0
362.9
Dilu-
tion
1:51
1:51
1:51
1:51
Sample
volume
(ml)
0.5
0.5
0.5
0.5
Test
series
(n)
10
10
10
10
CV
(%)
5.8
4.6
5.3
4.0
Imprecision between days
Concen- Dilu-
tration tion
x (μβ/1)
86.1 1 : 51
80.8 1 : 51
Sample
volume
(ml)
0.5
0.5
Test CV
series
(n) (%)
10 9.1
10 8.7
Accuracy
Found
concen-
tration
Oig/1)
296.0
300.3
303.7
308.9
309.4
139.0
141.0
144.0
Assigned
value
(Mg/1)
305.0
139,0
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diluted with sample diluent (phosphate, 0.01 mol/1, pH 7.5;
NaCl, 0.15 mol/1; EDTA, 20 mmol/1; bovine serum albumin,
1 g/1) (6) in a ratio from 1/100 to 1/1500.
Statistical analysis
For evaluation of results, imprecision within-run and between-
days, coefficient of correlation (r), standard principle compo-
nent analysis and paired t-test (p < 0.025) were performed as
described elsewhere (7—9).
Results and Discussion
Table 1 shows the condensed data for the imprecision of both
test kits. From these data it can be deduced that the highest
within-run and between-days coefficients of variation for the
2h-/4h-test kits were 5.8%/5.3% and 9.1%/8.7% respectively.
The recovery data of the assigned values of control materials
varied within the ± 3.5% range for both test kits (tabl. 1). The
range of linearity for the 2h-test kit version was between 1.2
g/l and 9.9 %/\.
The detection limit, defined as the mean absorbance of the
reagent blank plus three times its standard deviation, was about
1.0 §/1. Because of the wide measuring range it was necessary
to repeat analyses only in exceptional cases. The comparison
of elastase/arproteinase-inhibitor in plasma samples from 160
patients showed a good agreement (r = 0.97) between both test
kits (fig. 1).
The findings suggest that the 2 h-elastase/arproteinase-inhibi-
tor test kit is able to replace the 4 h-test kit version.
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Correlation between the elastase/arproteinase-inhibitor
concentrations using a 2 h- and 4 h-test kit version.
Standard principle component analysis:
y = l.Olx - 0.55
Regression line according to Passing & Bablok:
y = 0.99x + 2.45
Coefficient of correlation:
r = 0.97 = 160
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